FDA grants Breakthrough Therapy Designation for Roche's Alecensa (alectinib) for first-line treatment of people with ALK-positive NSCLC
- Details
- Category: Roche

Novartis reports over half of psoriasis patients do not reach the achievable treatment goal of clear skin in largest global survey
- Details
- Category: Novartis

Boehringer Ingelheim and SARAH CANNON Research Institute launch strategic collaboration to develop novel immune-oncology therapies
- Details
- Category: Boehringer Ingelheim

Amgen and Arrowhead Pharmaceuticals announce two cardiovascular collaborations
- Details
- Category: Amgen

Sandoz invites young entrepreneurs to enter #SandozHACk, a global competition to help solve healthcare access challenges
- Details
- Category: Novartis

Bristol-Myers Squibb and Nektar Therapeutics announce oncology clinical collaboration to evaluate the combination of Opdivo (nivolumab) and NKTR-214
- Details
- Category: Bristol-Myers Squibb

Pfizer decides remaining one company best positions company to maximize future value creation
- Details
- Category: Pfizer

More Pharma News ...
- Novel Novartis malaria compound shows potential to be effective against infections resistant to all currently available antimalarial drugs
- Bristol-Myers Squibb awards first "Golden Tickets" for LabCentral to PanTher, Suono Bio
- Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 billion
- Novartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy Congress
- Pfizer launches new "Moodivator" app to help support, encourage and motivate people with depression
- PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
- Sanofi and Verily Life Sciences announce launch of Onduo, a joint venture to develop comprehensive diabetes management platform